Helpful tool for COVID-19 test & vaccine developers
The quantitative Actim ELISA SARS-CoV-2 IgG test detects recent COVID-19 infection in just 2 hours – even symptomless.
The test helps fight the coronavirus pandemic in many ways:
- Offers test developers a highly reliable comparison method for product verifications
- Can be used to investigate immune response to vaccine candidates
- Provides essential data for disease control measures, pandemic analysis, and epidemiological research
Actim ELISA SARS-CoV-2 IgG detects recent COVID-19 infection with outstanding specificity (98%) and sensitivity (96 %), and is one of the most reliable serological COVID-19 ELISA tests on the market.